Go Pro

BioSyent (RX) News Today

BioSyent logo
C$15.95 +0.11 (+0.69%)
As of 12:55 PM Eastern

BioSyent Latest News

BioSyent Declares Third Quarter 2026 Dividend
BioSyent Releases Financial Results for Q2 and H1 2026
BioSyent Declares Second Quarter 2026 Dividend
BioSyent Announces Grant of Restricted Share Units
BioSyent to Acquire Oral Science Inc.
BioSyent Declares First Quarter 2026 Dividend
BioSyent Declares Fourth Quarter 2025 Dividend
BioSyent Releases Financial Results for Q3 and YTD 2025
BioSyent Declares Third Quarter 2025 Dividend
BioSyent Releases Financial Results for Q2 and H1 2025
Biosyent Inc. Stock Price History
BioSyent (CVE:RX) Has Announced A Dividend Of CA$0.05
BioSyent Inc. (RX.V)
Calculating The Fair Value Of BioSyent Inc. (CVE:RX)
BioSyent Inc. (BIOYF)
BioSyent Inc.

BioSyent Media Mentions By Week

BioSyent Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RX
News Sentiment

0.70

0.89

Average
Healthcare
News Sentiment

BioSyent News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RX Articles
This Week

3

0

RX Articles
Average Week

BioSyent Trends on MarketBeat

This week vs. last week
Searches
1
Page Views
272
+33%
Get BioSyent News Delivered to You Automatically

Sign up to receive the latest news and ratings for RX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for BioSyent dated 8/20/2026.
From Our Partners